GlassScriptPhysician profile
Gautam Bhatia
NPI 1881911915
$30,566.17
in general payments reported to CMS, 2019-2025
32 companies · $3,908 in 2025
The $3,908 reported for 2025 was more than what 79% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,184 · 2020: $431 · 2021: $1,293 · 2022: $4,708 · 2023: $9,911 · 2024: $7,132 · 2025: $3,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,601 · Education: $7,155 · Consulting Fee: $3,180 · Travel and Lodging: $3,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,601.32 |
| Education | $7,155.00 |
| Consulting Fee | $3,180.00 |
| Travel and Lodging | $3,014.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $14,678.66 | 2021-2025 | Tisseel, Floseal, Preveleak |
| Atricure, INC. | $4,492.38 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Artivion, INC. | $2,414.44 | 2023-2025 | Cardiac Non-Synergraft, Cryovalve Sg Pulmonary Human Heart Valve, Amds-Ascyrus Medical |
| Abbott Laboratories | $2,062.04 | 2019-2025 | Epic |
| Edwards Lifesciences Corporation | $1,796.64 | 2019-2025 | Sapien 3 Ultra Resilia, Hemosphere, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $1,575.33 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $979.80 | 2019-2025 | Lifevest |
| Davol INC. | $355.66 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $351.19 | 2021-2025 | |
| Getinge USA Sales, LLC | $350.15 | 2019-2023 | Cardiohelp |
| Becton, Dickinson and Company | $214.19 | 2024-2025 | Swan-Ganz |
| Stryker Corporation | $168.56 | 2023 | Spy-Phi System |
| Cook Medical LLC | $125.37 | 2024 | Zenith Alpha |
| Lsi Solutions INC | $108.89 | 2025 | Ram |
| La Jolla Pharmaceutical Company | $108.86 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $106.76 | 2024-2025 | Onpattro |
| Cvrx, INC. | $86.38 | 2022-2025 | Barostim Neo System |
| Amgen INC. | $83.12 | 2023-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $73.23 | 2024-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $64.63 | 2024-2025 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $57.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.10 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.73 | 2022-2023 | Camzyos |
| Aroa Biosurgery Incorporated | $39.92 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.59 | 2023-2024 | Jardiance |
| Medtronic, INC. | $29.17 | 2025 | Avalus |
| Acera Surgical, INC. | $22.39 | 2025 | Restrata Wound Matrix |
| Nuwellis, INC. | $21.76 | 2021 | |
| Livanova USA, INC. | $21.39 | 2019 | |
| Novo Nordisk INC | $21.34 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $14.27 | 2024 | Arcalyst |
| Solventum Corporation | $13.38 | 2024 | V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gautam Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.